This session provides an introduction to the volatile anaesthetic agents explaining the important pharmacokinetic properties with particular attention to gaining understanding and an appreciation of the relevance of the novel concepts of MAC, oil:gas coef
This session covers the storage, production and physicochemical properties of nitrous oxide, N2O. It moves on to examine the Concentration Effect and Second Gas Effect. The physicochemical properties of xenon, Xe, are detailed, along with its s
This session describes the use of benzodiazepines in anaesthesia and intensive care. Other sedative agents are compared with benzodiazepines, particularly those that are available for use in the intensive care setting.
This session describes the main barbiturate drugs used in anaesthesia: thiopental, methohexital and phenobarbital, including their pharmacology, clinical effects and uses.
This session covers the induction agent etomidate. Etomidate (in clinical use since 1972) has a very stable haemodynamic profile. However, due to the inhibition of adrenocortical steroid synthesis after a single dose or infusion, the popularity of etomida
This session will provide an understanding of the properties that make up the ideal intravenous induction agent whilst also listing how the currently available agents meet these ideals. Reference will be made to historical agents where they illustrate imp
This session examines the local anaesthetics used in clinical practice including their structure, mechanism of action, safe doses and the potential side-effects.